{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:55:47Z","timestamp":1790776547194,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.compbiomed.2021.104461","type":"journal-article","created":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T01:17:20Z","timestamp":1619918240000},"page":"104461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Predictors of progression through the cascade of care to a cure for hepatitis C patients using decision trees and random forests"],"prefix":"10.1016","volume":"134","author":[{"given":"Jasmine Ye","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8834-4363","authenticated-orcid":false,"given":"Vicki Stover","family":"Hertzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2021.104461_bib1","series-title":"Surveillance for Viral Hepatitis \u2013 United States","year":"2017"},{"issue":"4","key":"10.1016\/j.compbiomed.2021.104461_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"Natural history of hepatitis C","volume":"44","author":"Lingala","year":"2015","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104461_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int. J. Med. Sci."},{"issue":"Suppl 5","key":"10.1016\/j.compbiomed.2021.104461_bib4","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"20","key":"10.1016\/j.compbiomed.2021.104461_bib5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMp1302973","article-title":"Hepatitis C in the United States","volume":"368","author":"Holmberg","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiomed.2021.104461_bib6","unstructured":"Smith BD, Patel N, Beckett GA, et al. Hepatitis C Virus Antibody Prevalence, Correlates and Predictors Among Persons Born from 1945 through 1965, United States, 1999-2008 [abstract]. Presented at: American Association for the Study of Liver Disease; November 6, 2011; San Francisco, CA."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104461_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, national health and nutrition examination survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2021.104461_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States","volume":"31","author":"Armstrong","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2021.104461_bib9","series-title":"Global Health Sector Strategy on Viral Hepatitis 2016-2021: towards Ending Viral Hepatitis","author":"World Health Organization","year":"2016"},{"issue":"8","key":"10.1016\/j.compbiomed.2021.104461_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.cgh.2013.11.032","article-title":"Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C","volume":"12","author":"Younossi","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.compbiomed.2021.104461_bib12","first-page":"77","article-title":"Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients","volume":"19","author":"Neary","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"5 Pt 1","key":"10.1016\/j.compbiomed.2021.104461_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"24","key":"10.1016\/j.compbiomed.2021.104461_bib14","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"J. Am. Med. Assoc."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.104461_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.compbiomed.2021.104461_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101554","article-title":"The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis","volume":"9","author":"Yehia","year":"2014","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.compbiomed.2021.104461_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/jvh.12173","article-title":"The new paradigm of hepatitis C therapy: integration of oral therapies into best practices","volume":"20","author":"Afdhal","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"6","key":"10.1016\/j.compbiomed.2021.104461_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciq243","article-title":"The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection","volume":"52","author":"Gardner","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.104461_bib20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11606-018-4649-6","article-title":"Race and hepatitis C care continuum in an underserved birth cohort","volume":"34","author":"Kim","year":"2018","journal-title":"J. Gen. Intern. Med."},{"issue":"8","key":"10.1016\/j.compbiomed.2021.104461_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6371","article-title":"Prevalence of hepatitis C virus infection in US States and the District of Columbia, 2013 to 2016","volume":"1","author":"Rosenberg","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.compbiomed.2021.104461_bib22","series-title":"Modern Data Science with R","author":"Baumer","year":"2017"},{"issue":"7","key":"10.1016\/j.compbiomed.2021.104461_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/MCG.0000000000000857","article-title":"Uptake of and factors associated with direct-acting antiviral therapy among patients in the chronic hepatitis cohort study, 2014 to 2015","volume":"52","author":"Spradling","year":"2018","journal-title":"J. Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.compbiomed.2021.104461_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199174","article-title":"Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era","volume":"13","author":"Zuckerman","year":"2018","journal-title":"PloS One"},{"issue":"1\u20132","key":"10.1016\/j.compbiomed.2021.104461_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.09.008","article-title":"Barriers associated with the treatment of hepatitis C virus infection among illicit drug users","volume":"93","author":"Grebely","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.104461_bib26","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/apt.14328","article-title":"Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents","volume":"46","author":"Lin","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104461_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/apc.2014.0033","article-title":"Barriers to hepatitis C antiviral therapy in HIV\/HCV co-infected patients in the United States: a review","volume":"28","author":"Oramasionwu","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.compbiomed.2021.104461_bib28","unstructured":"Reproduced with Permission of the Publisher from World Health Organization. ICD-10 Version:2014 2014; https:\/\/icd.who.int\/browse10\/2014\/en#\/, 2019."},{"key":"10.1016\/j.compbiomed.2021.104461_bib29","author":"Yoshida"},{"issue":"15","key":"10.1016\/j.compbiomed.2021.104461_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.21037\/atm.2016.05.14","article-title":"Decision tree modeling using R","volume":"4","author":"Zhang","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.compbiomed.2021.104461_bib31","author":"Therneau"},{"key":"10.1016\/j.compbiomed.2021.104461_bib32","series-title":"Caret: Classification and Regression Training. R Package Version 6.0-84","author":"Kuhn","year":"2019"},{"issue":"3","key":"10.1016\/j.compbiomed.2021.104461_bib33","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R. News"},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104461_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jvh.13199","article-title":"Defining the hepatitis C cure cascade in an urban health system using the electronic health record","volume":"27","author":"Miller","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"Suppl 4","key":"10.1016\/j.compbiomed.2021.104461_bib35","doi-asserted-by":"crossref","first-page":"S555","DOI":"10.2105\/AJPH.2014.302090","article-title":"Impact of race\/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care","volume":"104","author":"Backus","year":"2014","journal-title":"Am. J. Publ. Health"},{"issue":"8","key":"10.1016\/j.compbiomed.2021.104461_bib36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ajg.2015.31","article-title":"Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study","volume":"110","author":"Ditah","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104461_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajem.2018.08.067","article-title":"Advanced liver fibrosis and care continuum in emergency department patients with chronic hepatitis C","volume":"37","author":"Hsieh","year":"2019","journal-title":"Am. J. Emerg. Med."},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104461_bib38","first-page":"147","article-title":"Gender differences in the utilization of health care services","volume":"49","author":"Bertakis","year":"2000","journal-title":"J. Fam. Pract."},{"issue":"8","key":"10.1016\/j.compbiomed.2021.104461_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161241","article-title":"Health disparities in hepatitis C screening and linkage to care at an integrated health system in Southeast Michigan","volume":"11","author":"Bourgi","year":"2016","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.compbiomed.2021.104461_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135645","article-title":"Drug authorization for sofosbuvir\/ledipasvir (Harvoni) for chronic HCV infection in a real-world cohort: a new barrier in the HCV care cascade","volume":"10","author":"Do","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104461_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/QAI.0000000000001949","article-title":"HCV screening and treatment uptake among patients in HIV care during 2014-2015","volume":"80","author":"Radwan","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"22","key":"10.1016\/j.compbiomed.2021.104461_bib42","article-title":"Racial disparities in treatment rates for chronic hepatitis C: analysis of a population-based cohort of 73,665 patients in the United States","volume":"95","author":"Vutien","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104461_bib43","first-page":"232","article-title":"Monitoring the hepatitis C care cascade using administrative claims data","volume":"24","author":"Isenhour","year":"2018","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.compbiomed.2021.104461_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13027-016-0071-z","article-title":"Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States","volume":"11","author":"Rosenthal","year":"2016","journal-title":"Infect. Agents Canc."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104461_bib45","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/hep.29308","article-title":"High hepatitis C cure rates among black and nonblack human immunodeficiency virus-infected adults in an urban center","volume":"66","author":"Falade-Nwulia","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.compbiomed.2021.104461_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/M15-0406","article-title":"Restrictions for medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States","volume":"163","author":"Barua","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2021.104461_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M15-0320","article-title":"Limited access to new hepatitis C virus treatment under state Medicaid programs","volume":"163","author":"Canary","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.compbiomed.2021.104461_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ofid\/ofy202","article-title":"Hepatitis C within a single health system: progression along the cascade to cure is higher for those with substance misuse when linked to a clinic with embedded support services","volume":"5","author":"Sherbuk","year":"2018","journal-title":"Open Forum Infect. Dis."},{"issue":"7","key":"10.1016\/j.compbiomed.2021.104461_bib49","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cgh.2016.03.040","article-title":"Disparities in absolute denial of modern hepatitis C therapy by type of insurance","volume":"14","author":"Lo Re","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104461_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/jvh.12507","article-title":"Public health clinic-based hepatitis C testing and linkage to care in Baltimore","volume":"23","author":"Falade-Nwulia","year":"2016","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104461_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MCG.0000000000000872","article-title":"Race, age, and geography impact hepatitis C genotype distribution in the United States","volume":"53","author":"Gordon","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2021.104461_bib52","first-page":"53","article-title":"Novel drugs in the management of difficult-to-treat hepatitis C genotypes","volume":"5","author":"Cartwright","year":"2013","journal-title":"Hepatol. Med."},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104461_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/civ220","article-title":"The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus","volume":"61","author":"Rein","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.compbiomed.2021.104461_bib54","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/MEG.0000000000000961","article-title":"Short article: alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center","volume":"29","author":"Sims","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.compbiomed.2021.104461_bib55","first-page":"110","article-title":"Barriers to treatment access for chronic hepatitis C virus infection: a case series","volume":"25","author":"Millman","year":"2017","journal-title":"Top. Antivir. Med."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521002559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521002559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:02:14Z","timestamp":1790773334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482521002559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":53,"alternative-id":["S0010482521002559"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104461","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of progression through the cascade of care to a cure for hepatitis C patients using decision trees and random forests","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104461"}}